文献速递中毒与环境急症

摄入后2至4小时铁浓度对预测毒性的效用

Utility of iron concentration two to four hours post ingestion in predicting toxicity.
PubMed 文献 · Am J Emerg Med · 2024-10-26
一句话结论仅有轻微胃肠道症状且摄入后2-4小时铁浓度≤300 μg/dL的患者,后续发展为潜在毒性浓度的可能性低(阴性预测值100%)。

本研究为单中心回顾性研究,纳入2015年1月1日至2020年1月1日期间向区域中毒中心报告的75例以口服铁剂为主摄入的患者,旨在确定摄入后2-4小时的症状和铁浓度能否预测4小时及以后铁浓度的发展。主要结局为4小时及以后铁浓度≥350 μg/dL的发生率。结果显示,仅有轻微症状且2-4小时铁浓度≤300 μg/dL的患者无一例后续浓度≥350 μg/dL(阴性预测值100%);5例使用去铁胺治疗的患者2-4小时浓度均>300 μg/dL。结论认为,仅有轻微胃肠道症状且2-4小时铁浓度≤300 μg/dL的患者不太可能进一步发展毒性,该切点预测后续潜在毒性浓度的敏感性为100%、特异性为54%。

要点

  • 仅有轻微胃肠道症状(腹部不适、恶心、呕吐或腹泻而无全身毒性证据)且摄入后2-4小时铁浓度≤300 μg/dL的患者,后续无一例铁浓度≥350 μg/dL(阴性预测值100%)。
  • 5例接受去铁胺治疗的患者,摄入后2-4小时铁浓度均>300 μg/dL。
  • 2-4小时铁浓度≤300 μg/dL是预测后续潜在毒性浓度的理想切点,敏感性100%、特异性54%。
  • 传统上认为有症状者铁浓度350 μg/dL、无症状者500 μg/dL考虑中毒并可能需治疗,且一般推荐至少摄入后4小时采血以避免假性低值。

适用人群与场景

  • 以口服铁剂为主要摄入、向区域中毒中心报告的患者,研究期间为2015年1月1日至2020年1月1日。

诊断标准与关键阈值

  • 传统毒性阈值:有症状者铁浓度350 μg/dL,无症状者500 μg/dL,视为中毒并可能需治疗以预防失代偿。
  • 一般推荐至少摄入后4小时获取铁浓度,以提供足够吸收时间并避免假性低铁浓度。
  • 本研究评估的切点:摄入后2-4小时铁浓度≤300 μg/dL。

红旗征与不能漏的情况

  • 出现全身毒性证据(超出腹部不适、恶心、呕吐或腹泻等轻微胃肠道症状)时,不属于本研究所述低风险人群。
  • 摄入后2-4小时铁浓度>300 μg/dL者,本研究中全部5例接受了去铁胺治疗。

研究设计与关键结果

  • 研究类型:单中心回顾性研究,纳入75例以口服铁剂为主摄入的患者。
  • 主要结局:4小时及以后铁浓度≥350 μg/dL的发生率;仅有轻微症状且2-4小时铁浓度≤300 μg/dL的患者中,后续无一例达到≥350 μg/dL(阴性预测值100%)。
  • 去铁胺治疗5例,其摄入后2-4小时铁浓度均>300 μg/dL。
  • 2-4小时铁浓度≤300 μg/dL预测后续潜在毒性浓度的敏感性100%、特异性54%。

证据类型、等级与局限

  • 证据类型:单中心回顾性病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于仅有轻微胃肠道症状且摄入后2-4小时铁浓度≤300 μg/dL的患者,作者认为不太可能进一步发展毒性。
  • 作者认为,摄入后2-4小时铁浓度≤300 μg/dL是预测后续潜在毒性浓度的理想切点(敏感性100%、特异性54%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Iron products are widely available over the counter and have the potential to cause serious toxicity. Iron concentrations can be used to prognosticate and guide treatment during acute ingestions. Traditionally, a concentration of 350 μg/dL with symptoms, or 500 μg/dL without symptoms, is considered toxic and will likely need treatment to prevent decompensation. It is generally recommended that an iron concentration is obtained at least 4 h after exposure to provide adequate absorption time and avoid falsely low iron concentrations. Despite this, many iron overdoses have concentrations drawn immediately upon patient presentation. The utility of an iron concentration drawn before 4 h in assessing exposure risk is not clear. The purpose of this study is to determine if patients' symptoms and iron concentrations obtained between 2 and 4 h can predict the development of iron concentrations after 4 h.

METHODS: This is a single-center, retrospective study of patient cases with a primary ingestion of oral iron reported to a regional poison center from January 1, 2015 to January 1, 2020. The primary outcome is the incidence of an iron concentration of 350 μg/dL or greater at or beyond 4 h. Secondary outcomes include the incidence of antidotal deferoxamine administration, incidence of iron concentration > 500 μg/dL, incidence of positive findings on abdominal radiography, and time to highest reported iron concentration.

RESULT: A total of 75 patients were included in this study. No patients who developed at most minor symptoms (abdominal discomfort, nausea, vomiting, or diarrhea without evidence of systemic toxicity) and had a 2-4 h concentration ≤ 300 μg/dL symptoms had a subsequent concentration ≥ 350 μg/dL (negative predictive value [NPV] 100 %). Deferoxamine was used to treat five patients, all reached concentrations of > 300 μg/dL 2-4 h post-ingestion.

CONCLUSION: Patients with only minor GI symptoms and an iron concentration of ≤ 300 μg/dL between 2 and 4 h post-ingestion are unlikely to develop further toxicity. In this case series, a concentration of 300 μg/dL or less between 2 and 4 h was the ideal cutoff to predicting subsequent potentially toxic concentrations, with a sensitivity of 100 % and a specificity of 54 %.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Fox H, Jansen A, Theobald J, et al. Utility of iron concentration two to four hours post ingestion in predicting toxicity. Am J Emerg Med. 2024. PMID: 39509998. doi:10.1016/j.ajem.2024.10.042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。